These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 7889326)

  • 41. The highly conserved domain of RND multidrug efflux pumps in pathogenic Gram-negative bacteria.
    Shahini Shams Abadi M; Gholipour A; Hadi N
    Cell Mol Biol (Noisy-le-grand); 2018 Oct; 64(13):79-83. PubMed ID: 30403600
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Multidrug efflux pumps and antimicrobial resistance in Pseudomonas aeruginosa and related organisms.
    Poole K
    J Mol Microbiol Biotechnol; 2001 Apr; 3(2):255-64. PubMed ID: 11321581
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Polysaccharide export outer membrane proteins in Gram-negative bacteria.
    Yuan B; Cheng A; Wang M
    Future Microbiol; 2013 Apr; 8(4):525-35. PubMed ID: 23534363
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Quantitative contribution of efflux to multi-drug resistance of clinical Escherichia coli and Pseudomonas aeruginosa strains.
    Cunrath O; Meinel DM; Maturana P; Fanous J; Buyck JM; Saint Auguste P; Seth-Smith HMB; Körner J; Dehio C; Trebosc V; Kemmer C; Neher R; Egli A; Bumann D
    EBioMedicine; 2019 Mar; 41():479-487. PubMed ID: 30852163
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Structure and mechanism of bacterial tripartite efflux pumps.
    Neuberger A; Du D; Luisi BF
    Res Microbiol; 2018; 169(7-8):401-413. PubMed ID: 29787834
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Targeting LPS biosynthesis and transport in gram-negative bacteria in the era of multi-drug resistance.
    Romano KP; Hung DT
    Biochim Biophys Acta Mol Cell Res; 2023 Mar; 1870(3):119407. PubMed ID: 36543281
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Outer membranes and efflux: the path to multidrug resistance in Gram-negative bacteria.
    Poole K
    Curr Pharm Biotechnol; 2002 Jun; 3(2):77-98. PubMed ID: 12022261
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Polyamine effects on antibiotic susceptibility in bacteria.
    Kwon DH; Lu CD
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2070-7. PubMed ID: 17438056
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Assessing Antibiotic Permeability of Gram-Negative Bacteria via Nanofluidics.
    Hong S; Moritz TJ; Rath CM; Tamrakar P; Lee P; Krucker T; Lee LP
    ACS Nano; 2017 Jul; 11(7):6959-6967. PubMed ID: 28605582
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Bacterial efflux pumps - their role in antibiotic resistance and potential inhibitors].
    Hricová K; Kolář M
    Klin Mikrobiol Infekc Lek; 2014 Dec; 20(4):116-20. PubMed ID: 25702054
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mechanisms of solvent tolerance in gram-negative bacteria.
    Ramos JL; Duque E; Gallegos MT; Godoy P; Ramos-Gonzalez MI; Rojas A; Teran W; Segura A
    Annu Rev Microbiol; 2002; 56():743-68. PubMed ID: 12142492
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efflux Pump Inhibitors: A Novel Approach to Combat Efflux-Mediated Drug Resistance in Bacteria.
    Wang Y; Venter H; Ma S
    Curr Drug Targets; 2016; 17(6):702-19. PubMed ID: 26424403
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The development of efflux pump inhibitors to treat Gram-negative infections.
    Blanco P; Sanz-García F; Hernando-Amado S; Martínez JL; Alcalde-Rico M
    Expert Opin Drug Discov; 2018 Oct; 13(10):919-931. PubMed ID: 30198793
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Impact of Efflux Pump Inhibitors on the Activity of Selected Non-Antibiotic Medicinal Products against Gram-Negative Bacteria.
    Laudy AE; Kulińska E; Tyski S
    Molecules; 2017 Jan; 22(1):. PubMed ID: 28085074
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Combination studies between polycationic peptides and clinically used antibiotics against Gram-positive and Gram-negative bacteria.
    Giacometti A; Cirioni O; Del Prete MS; Paggi AM; D'Errico MM; Scalise G
    Peptides; 2000 Aug; 21(8):1155-60. PubMed ID: 11035200
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The forgotten Gram-negative bacilli: what genetic determinants are telling us about the spread of antibiotic resistance.
    Gootz TD
    Biochem Pharmacol; 2006 Mar; 71(7):1073-84. PubMed ID: 16359640
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reconstitution of the activity of RND efflux pumps: a "bottom-up" approach.
    Puvanendran D; Cece Q; Picard M
    Res Microbiol; 2018; 169(7-8):442-449. PubMed ID: 29217371
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Multiantibiotic resistance caused by active drug extrusion in Pseudomonas aeruginosa and other gram-negative bacteria.
    Nakae T
    Microbiologia; 1997 Sep; 13(3):273-84. PubMed ID: 9353746
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Practical applications and feasibility of efflux pump inhibitors in the clinic--a vision for applied use.
    Lomovskaya O; Bostian KA
    Biochem Pharmacol; 2006 Mar; 71(7):910-8. PubMed ID: 16427026
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mutations in MexB that affect the efflux of antibiotics with cytoplasmic targets.
    Ohene-Agyei T; Lea JD; Venter H
    FEMS Microbiol Lett; 2012 Aug; 333(1):20-7. PubMed ID: 22568688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.